Department of Epidemiology, Human Genetics Center and Environmental Science, School of Public Health, University of Texas Health Science Center at Houston (G.L., N.Q.H.N., E.B., J.M., B.Y.).
Metabolon Inc, Research Triangle Park, Morrisville, NC (K.E.W.).
Circ Heart Fail. 2024 Mar;17(3):e010896. doi: 10.1161/CIRCHEARTFAILURE.123.010896. Epub 2024 Mar 1.
Older adults have markedly increased risks of heart failure (HF), specifically HF with preserved ejection fraction (HFpEF). Identifying novel biomarkers can help in understanding HF pathogenesis and improve at-risk population identification. This study aimed to identify metabolites associated with incident HF, HFpEF, and HF with reduced ejection fraction and examine risk prediction in older adults.
Untargeted metabolomic profiling was performed in Black and White adults from the ARIC study (Atherosclerosis Risk in Communities) visit 5 (n=3719; mean age, 75 years). We applied Cox regressions to identify metabolites associated with incident HF and its subtypes. The metabolite risk score (MRS) was constructed and examined for associations with HF, echocardiographic measures, and HF risk prediction. Independent samples from visit 3 (n=1929; mean age, 58 years) were used for replication.
Sixty metabolites (hazard ratios range, 0.79-1.49; false discovery rate, <0.05) were associated with incident HF after adjusting for clinical risk factors, eGFR, and NT-proBNP (N-terminal pro-B-type natriuretic peptide). Mannonate, a hydroxy acid, was replicated (hazard ratio, 1.36 [95% CI, 1.19-1.56]) with full adjustments. MRS was associated with an 80% increased risk of HF per SD increment, and the highest MRS quartile had 8.7× the risk of developing HFpEF than the lowest quartile. High MRS was also associated with unfavorable values of cardiac structure and function. Adding MRS over clinical risk factors and NT-proBNP improved 5-year HF risk prediction C statistics from 0.817 to 0.850 (∆C, 0.033 [95% CI, 0.017-0.047]). The association between MRS and incident HF was replicated after accounting for clinical risk factors (<0.05).
Novel metabolites associated with HF risk were identified, elucidating disease pathways, specifically HFpEF. An MRS was associated with HF risk and improved 5-year risk prediction in older adults, which may assist at at-risk population identification.
老年人患心力衰竭(HF),尤其是射血分数保留型心力衰竭(HFpEF)的风险明显增加。鉴定新的生物标志物有助于了解 HF 的发病机制并改善高危人群的识别。本研究旨在鉴定与新发 HF、HFpEF 和射血分数降低型心力衰竭相关的代谢物,并研究其在老年人中的风险预测作用。
在 ARIC 研究(社区动脉粥样硬化风险研究)第五次访视中(n=3719;平均年龄 75 岁)对黑人和白人成年人进行非靶向代谢组学分析。我们应用 Cox 回归分析鉴定与新发 HF 及其亚型相关的代谢物。构建代谢物风险评分(MRS)并评估其与 HF、超声心动图指标及 HF 风险预测的相关性。使用第三次访视(n=1929;平均年龄 58 岁)中的独立样本进行验证。
调整临床危险因素、eGFR 和 NT-proBNP(N 末端 B 型利钠肽前体)后,60 种代谢物(风险比范围 0.79-1.49;假发现率 <0.05)与新发 HF 相关。羟基酸甘露酸盐得到了验证(危险比 1.36[95%CI,1.19-1.56]),且经过充分调整。MRS 与每增加 1 个标准差 HF 风险增加 80%相关,最高四分位数 MRS 发生 HFpEF 的风险是最低四分位数的 8.7 倍。MRS 升高还与心脏结构和功能的不良值相关。在临床危险因素和 NT-proBNP 的基础上增加 MRS 可将 5 年 HF 风险预测 C 统计值从 0.817 提高至 0.850(∆C,0.033[95%CI,0.017-0.047])。在考虑临床危险因素后(<0.05),MRS 与新发 HF 的相关性得到了验证。
本研究鉴定了与 HF 风险相关的新型代谢物,阐明了疾病通路,尤其是 HFpEF。MRS 与 HF 风险相关,并可改善老年人的 5 年风险预测,有助于高危人群的识别。